% Encoding: UTF-8

@Online{EMA-2018-09-QA.MSD.DISSO,
  author           = {{European Medicines Agency}},
  date             = {2018-09},
  title            = {Question and answer on the adequacy of the {Mahalanobis} distance to assess the comparability of drug dissolution profiles},
  url              = {https://www.ema.europa.eu/documents/scientific-guideline/question-answer-adequacy-mahalanobis-distance-assess-comparability-drug-dissolution-profiles_en.pdf},
  urldate          = {2018-12-04},
  version          = {Questions and Answers},
  creationdate     = {2021-07-15T18:40:38},
  file             = {:JabRef/1.Reg.Guide/2.EMA/q.a.adequacy.msd.assess.comparab.dissolution.prof_EMA-2018-09-QA.MSD.DISSO.pdf:PDF},
  keywords         = {dissolution, statistics, f2, bootstrap, similarity},
  modificationdate = {2021-07-15T18:40:38},
  owner            = {Zhengguo Xu},
  referencenumber  = {EMA/810713/2017},
  shortauthor      = {EMA},
}

@Article{Davit-2013-03-BA,
  author           = {Davit, Barbara M. and Stier, Ethan and Jiang, Xiaojian and Anand, Om},
  date             = {2013-03},
  journaltitle     = {Biopharma Asia},
  title            = {Expectations of the {US-FDA} regarding dissolution data in generic drug regulatory submissions},
  number           = {2},
  url              = {https://biopharma-asia.com/magazine-articles/expectations-of-the-us-fda-regarding-dissolution-data-in-generic-drug-regulatory-submissions/},
  urldate          = {2017-07-03},
  volume           = {2},
  creationdate     = {2021-07-15T18:41:56},
  file             = {:JabRef/Pharmaceut.Sci/Dissolution/1.Article/Davit-2013-03-BA_expectation.FDA.dissolution.generic.drug.submit.pdf:PDF},
  journal          = {Biopharma Asia},
  keywords         = {dissolution, regulation},
  modificationdate = {2021-07-15T18:41:56},
  owner            = {Zhengguo Xu},
}

@InProceedings{Lum-2019-05-WS,
  author           = {Lum, Susan},
  booktitle        = {In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, and When},
  date             = {2019-05},
  title            = {Health {Canada}'s Current Practice and Challenges in the Evaluation of Dissolution Profile Comparisons in Support of Minor/Moderate Product Quality Changes: Case Studies.},
  url              = {https://www.pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/dissolution-similarity/lum-slides_revised.pdf},
  urldate          = {2021-03-12},
  creationdate     = {2021-07-15T18:42:31},
  file             = {:JabRef/Pharmaceut.Sci/Dissolution/2.Misc/Lum-2021-05-WS_Canada.dissolution.comparison.pdf:PDF},
  keywords         = {regulation, dissolution, similarity, f2, MSD},
  modificationdate = {2021-07-15T18:42:31},
  owner            = {Zhengguo Xu},
}

@InProceedings{Mandula-2019-05-WS,
  author           = {Mandula, Haritha},
  booktitle        = {In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, and When},
  date             = {2019-05},
  title            = {Rational Statistical Analysis Practice in Dissolution Profile Comparison: {FDA} Perspective},
  url              = {https://www.pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/dissolution-similarity/mandula-slides.pdf},
  urldate          = {2021-03-12},
  creationdate     = {2021-07-15T18:44:46},
  file             = {:JabRef/Pharmaceut.Sci/Dissolution/2.Misc/Mandula-2019-05-WS_FDA.disso.comp.pdf:PDF},
  keywords         = {regulation, dissolution, similarity, f2, MSD},
  modificationdate = {2021-07-15T18:44:46},
  owner            = {Zhengguo Xu},
}

@Online{EMA-2010-INV.BE,
  author           = {{European Medicines Agency}},
  date             = {2010},
  title            = {Guideline on the Investigation of Bioequivalence},
  url              = {https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf},
  urldate          = {2021-02-03},
  version          = {final},
  creationdate     = {2021-07-17T12:22:58},
  keywords         = {guidance, bioequivalence, immediate-release, regulation, EMA},
  modificationdate = {2021-07-17T12:22:58},
  owner            = {Zhengguo Xu},
  referencenumber  = {CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **},
  shortauthor      = {EMA},
}

@Online{USFDA-1997-08-DISSO.IR.SOLID.ORAL,
  author            = {{U.S. FDA}},
  date              = {1997-08},
  title             = {Guidance for {Industry}. {Dissolution} Testing of Immediate Release Solid Oral Dosage Forms},
  url               = {https://www.fda.gov/media/70936/download},
  urldate           = {2017-03-27},
  version           = {final},
  bibtexkeyaddonpre = {USFDA},
  creationdate      = {2021-07-17T12:23:48},
  file              = {:JabRef/1.Reg.Guide/1.USFDA/disso.test.IR.solid.oral.dosage.form_final_1997.08_USFDA-1997-08-DISSO.IR.SOLID.ORAL.pdf:PDF},
  keywords          = {guidance, dissolution},
  modificationdate  = {2021-07-17T15:48:19},
  owner             = {Zhengguo Xu},
  shortauthor       = {U.S.FDA},
}

@Online{HealthCanada-2017,
  author           = {{Health Canada}},
  date             = {2017},
  title            = {Guidance Document: Use of a Foreign-sourced Reference Product as a {Canadian} Reference Product},
  url              = {https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/canadian-reference-product-guidance.html},
  urldate          = {2021-02-03},
  creationdate     = {2021-07-17T12:24:57},
  modificationdate = {2021-07-17T12:24:57},
  owner            = {Zhengguo Xu},
}

@InBook{WHO-2017,
  author           = {{WHO}},
  booktitle        = {WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-first report.},
  date             = {2017},
  title            = {Multisource (generic) pharmaceutical products: guidelines on registration requirements toestablish interchangeability},
  url              = {https://apps.who.int/iris/bitstream/handle/10665/258720/9789241210034-eng.pdf?sequence=1&isAllowed=y},
  urldate          = {2021-02-03},
  creationdate     = {2021-07-17T12:25:43},
  institution      = {World Health Organization},
  modificationdate = {2021-07-17T12:25:43},
  owner            = {Zhengguo Xu},
}

@Online{MHLW2012,
  author           = {{Ministry of Health, Labour, and Welfare}},
  date             = {2012},
  title            = {Guideline for Bioequivalence Studies of GenericProducts.},
  url              = {http://www.nihs.go.jp/drug/be-guide(e)/Generic/GL-E_120229_BE.pdf},
  urldate          = {2021-02-03},
  creationdate     = {2021-07-17T12:26:43},
  modificationdate = {2021-07-17T12:26:43},
  owner            = {Zhengguo Xu},
}

@Online{ANVISA2010,
  author           = {{Ministério da Saúde Agência Nacional de Vigilância Sanitária}},
  date             = {2010},
  title            = {On Pharmaceutical Equivalence Studies and Comparative Dissolution Profile.},
  url              = {http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res0031_11_08_2010.html},
  urldate          = {2021-02-03},
  creationdate     = {2021-07-17T12:27:27},
  modificationdate = {2021-07-17T12:27:27},
  owner            = {Zhengguo Xu},
}

@Online{CDENMPA-2016,
  author           = {{Center for Drug Evaluation, NMPA}},
  date             = {2016},
  title            = {Guideline for the determination and comparison of dissolution profiles of solid oral dosage forms},
  url              = {http://www.cde.org.cn/attachmentout.do?mothed=list&id=1c96d2eb3da28239},
  creationdate     = {2021-07-17T12:28:16},
  modificationdate = {2021-07-17T12:28:16},
  owner            = {Zhengguo Xu},
}

@Online{USFDA-1997-02-SUPAC.IR.QA,
  author            = {{U.S. FDA}},
  date              = {1997-02},
  title             = {SUPAC-IR Questions and Answers about SUPAC-IR Guidance},
  url               = {https://www.fda.gov/regulatory-information/search-fda-guidance-documents/supac-ir-questions-and-answers-about-supac-ir-guidance},
  urldate           = {2017-03-29},
  bibtexkeyaddonpre = {USFDA},
  creationdate      = {2021-07-17T13:04:40},
  file              = {:JabRef/1.Reg.Guide/1.USFDA/IR.solid.dosage.form.SUPAC.CMC.disso.BE.QA_1997.02.18_USFDA-1997-02-SUPAC.IR.QA.pdf:PDF},
  keywords          = {guidance, SUPAC, immediate-release, dissolution, CMC, bioequivalence},
  modificationdate  = {2021-07-17T14:55:33},
  owner             = {Zhengguo Xu},
  shortauthor       = {U.S.FDA},
}

@Online{USFDA-1995-11-SUPAC.IR.CMC.DISSO.BE,
  author            = {{U.S. FDA}},
  date              = {1995-11},
  title             = {Guidance for {Industry}. {Immediate} Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation},
  url               = {https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070636.pdf},
  urldate           = {2017-03-29},
  version           = {final},
  bibtexkeyaddonpre = {USFDA},
  creationdate      = {2021-07-17T14:52:23},
  file              = {:JabRef/1.Reg.Guide/1.USFDA/IR.solid.dosage.form.SUPAC.CMC.disso.be_final_1995.11_USFDA-1995-11-SUPAC.IR.CMC.DISSO.BE.pdf:PDF},
  keywords          = {guidance, SUPAC, immediate-release, dissolution, bioequivalence, CMC},
  modificationdate  = {2021-07-17T14:52:23},
  owner             = {Zhengguo Xu},
  shortauthor       = {U.S.FDA},
}

@Online{HealthCanada-2019-07-Quality,
  author           = {{Health Canada}},
  date             = {2019-07},
  title            = {Guidance Document : Post-Notice of Compliance (NOC) Changes: Quality Document},
  url              = {https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/quality-document/guidance.html},
  urldate          = {2021-07-17},
  creationdate     = {2021-07-17T16:01:08},
  modificationdate = {2021-07-17T16:01:08},
  owner            = {Zhengguo Xu},
}

@Online{Mendyk-2019,
  author           = {Mendyk, Aleksander},
  date             = {2019},
  title            = {{bootf2BCA}},
  url              = {https://sourceforge.net/projects/bootf2bca/files/bootf2BCA_v1.2/},
  urldate          = {2021-02-03},
  creationdate     = {2021-07-18T02:40:32},
  modificationdate = {2021-07-18T02:40:32},
  owner            = {Zhengguo Xu},
}

@Article{Mendyk-2013-02-DT,
  author           = {Mendyk, Aleksander and Pacławski, Adam and Szlek, Jakub and Jachowicz, Renata},
  date             = {2013-02},
  journaltitle     = {Dissolution Technologies},
  title            = {{PhEq\textunderscore bootstrap}: open-source software for the simulation of $f_2$ distribution in cases of large variability in dissolution profiles},
  doi              = {10.14227/DT200113P13},
  number           = {1},
  pages            = {13--17},
  volume           = {20},
  creationdate     = {2021-07-18T02:40:32},
  file             = {Mendyk-2013-02-DT_PhEq_bootstrap.opensource.app.simu.f2.large.var.disso.pdf:JabRef/Pharmaceut.Sci/Dissolution/1.Article/Mendyk-2013-02-DT_PhEq_bootstrap.opensource.app.simu.f2.large.var.disso.pdf:PDF},
  journal          = {Dissolut. Technol.},
  keywords         = {dissolution, dissolution similarity},
  modificationdate = {2021-07-18T02:40:32},
  owner            = {Zhengguo Xu},
}

@Online{USFDA-2017-12-WAIVER.BABE.IR.BCS,
  author            = {{U.S. FDA}},
  date              = {2017-12},
  title             = {Guidance for {Industry}. {Waiver} of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System},
  url               = {https://www.gmp-compliance.org/files/guidemgr/UCM070246.pdf},
  urldate           = {2018-02-12},
  version           = {final},
  bibtexkeyaddonpre = {USFDA},
  comment           = {> 85% at 15 min, no comparison},
  creationdate      = {2021-07-18T03:48:17},
  file              = {:JabRef/1.Reg.Guide/1.USFDA/waiver.ba.be.IR.solid.oral.dosage.form.base.BCS_final_2017-12_USFDA-2017-12-WAIVER.BABE.IR.BCS.pdf:PDF},
  keywords          = {guidance, bioavailability, bioequivalence, biowaiver, BCS, immediate-release},
  modificationdate  = {2021-07-18T03:48:17},
  owner             = {Zhengguo Xu},
  shortauthor       = {U.S.FDA},
}

@Online{USFDA-1997-09-SUPAC.MR.CMC.DISSO.BE,
  author            = {{U.S. FDA}},
  date              = {1997-09},
  title             = {Guidance for {Industry}. {SUPAC-MR}: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation},
  url               = {https://www.fda.gov/media/70956/download},
  urldate           = {2017-03-29},
  version           = {final},
  bibtexkeyaddonpre = {USFDA},
  creationdate      = {2021-07-18T12:25:06},
  file              = {:JabRef/1.Reg.Guide/1.USFDA/SUPAC.MR.CMC.disso.be_final_1997.09_USFDA-1997-09-SUPAC.MR.CMC.DISSO.BE.pdf:PDF},
  keywords          = {guidance, SUPAC, modified-release, CMC, bioequivalence, dissolution},
  modificationdate  = {2021-07-18T12:25:24},
  owner             = {Zhengguo Xu},
  shortauthor       = {U.S.FDA},
}

@Article{Moore-1996-06-PT,
  author           = {Moore, Jeffrey W. and Flanner, Henry H.},
  date             = {1996-06},
  journaltitle     = {Pharmaceutical Technology},
  title            = {Mathematical comparison of dissolution profiles},
  number           = {6},
  pages            = {64--74},
  volume           = {20},
  creationdate     = {2021-07-20T02:49:25},
  file             = {Moore-1996-06-PT_math.comp.disso.pdf:JabRef/Pharmaceut.Sci/Dissolution/1.Article/Moore-1996-06-PT_math.comp.disso.pdf:PDF},
  journal          = {Pharm. Technol.},
  keywords         = {dissolution, dissolution similarity, pharmaceutical},
  modificationdate = {2021-07-20T02:49:25},
  owner            = {Zhengguo Xu},
}

@Article{Shah-1998-06-PR,
  author           = {Shah, Vinod P. and Tsong, Yi and Sathe, Pradeep and Liu, Jen-Pei},
  date             = {1998-06},
  journaltitle     = {Pharmaceutical Research},
  title            = {In vitro dissolution profile comparison---statistics and analysis of the similarity factor, f2},
  doi              = {10.1023/A:1011976615750},
  eprinttype       = {pubmed},
  number           = {6},
  pages            = {889--896},
  volume           = {15},
  creationdate     = {2021-07-20T02:51:00},
  file             = {Shah-1998-06-PR_in.vitro.dissol.profile.compa--stat.analysis.f2.pdf:JabRef/Pharmaceut.Sci/Dissolution/1.Article/Shah-1998-06-PR_in.vitro.dissol.profile.compa--stat.analysis.f2.pdf:PDF},
  journal          = {Pharm. Res.},
  keywords         = {dissolution, dissolution similarity, pharmaceutical},
  modificationdate = {2021-07-20T02:51:00},
  owner            = {Zhengguo Xu},
}

@InBook{Tsong-2018-EBS,
  author           = {Tsong, Yi and Sathe, Pradeep M. and Shah, Vinod P.},
  booktitle        = {Encyclopedia of Biopharmaceutical Statistics},
  date             = {2018},
  title            = {In Vitro Dissolution Profile Comparison},
  edition          = {4},
  editor           = {Chow, Shein-Chung},
  pages            = {1148--1154},
  publisher        = {CRC Press},
  creationdate     = {2021-07-20T02:51:48},
  modificationdate = {2021-07-20T02:51:48},
  owner            = {Zhengguo Xu},
}

@Article{Ma-2000-05-JBS,
  author           = {Ma, Mi-Chia and Wang, Betty B.C. and Liu, Jen-Pei and Tsong, Yi},
  date             = {2000-05},
  journaltitle     = {Journal of Biopharmaceutical Statistics},
  title            = {Assessment of similarity between dissolution profiles.},
  doi              = {10.1081/BIP-100101024},
  eprinttype       = {pubmed},
  number           = {2},
  pages            = {229--249},
  volume           = {10},
  creationdate     = {2021-07-26T13:28:55},
  file             = {:JabRef/Pharmaceut.Sci/Dissolution/1.Article/Ma-2000-05-JBS_assess.similar.disso.profile.pdf:PDF},
  journal          = {J. Biopharm. Stat.},
  keywords         = {dissolution similarity, dissolution, pharmaceutical},
  modificationdate = {2021-07-26T13:28:55},
  owner            = {Zhengguo Xu},
}

@Book{Davison-1997-Bootstrap,
  author           = {Davison, Anthony Christopher and Hinkley, David Victor},
  date             = {1997},
  title            = {Bootstrap Methods and Their Application},
  isbn             = {9780521573917},
  publisher        = {Cambridge University Press},
  creationdate     = {2021-07-26T14:23:39},
  modificationdate = {2021-07-26T14:23:39},
  owner            = {Zhengguo Xu},
}

@Article{Hyndman-1996-AS,
  author           = {Rob J. Hyndman and Yanan Fan},
  date             = {1996},
  journaltitle     = {The American Statistician},
  title            = {Sample Quantiles in Statistical Packages},
  doi              = {10.1080/00031305.1996.10473566},
  number           = {4},
  pages            = {361--365},
  volume           = {50},
  creationdate     = {2021-07-26T14:31:56},
  journal          = {Amer. Statist.},
  modificationdate = {2021-07-26T14:31:56},
  owner            = {Zhengguo Xu},
}

@Article{Xu-2021-CMPB,
  author           = {Xu, Zhengguo and Merino-Sanjuan, Matilde and Mangas-Sanjuan, Victor and García-Arieta, Alfredo},
  date             = {2021},
  journaltitle     = {Computer Methods and Programs in Biomedicine},
  title            = {Estimators and Confidence Intervals of $f_2$ Using Bootstrap Methodology for the Comparison of Dissolution Profiles},
  pubstate         = {submitted},
  creationdate     = {2021-07-26T14:38:32},
  journal          = {Comput. Methods Programs Biomed.},
  keywords         = {bootstrap, f2, dissolution},
  modificationdate = {2021-07-26T14:43:29},
  owner            = {Zhengguo Xu},
}

@Book{Efron1993AIttB,
  author           = {Efron, Bradley and Tibshirani, Robert},
  date             = {1993},
  title            = {An Introduction to the Bootstrap},
  isbn             = {9780412042317},
  publisher        = {Chapman \& Hall},
  creationdate     = {2021-07-26T14:44:54},
  modificationdate = {2021-07-26T14:44:54},
  owner            = {Zhengguo Xu},
}

@Comment{jabref-meta: databaseType:biblatex;}
